Page last updated: 2024-10-21

zopolrestat and Chronic Illness

zopolrestat has been researched along with Chronic Illness in 1 studies

zopolrestat: structure given in first source

Research Excerpts

ExcerptRelevanceReference
"45 mug equiv/g, respectively, when dosed with [(14)C]lidorestat at 10 mg/kg po)."1.33Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications. ( Dicioccio, AT; Geraci, LS; Gunn, DE; Jacot, JL; Jones, JH; Jones, ML; Mitschler, A; Petrova, T; Podjarny, AD; Sawicki, DR; Sredy, J; Van Zandt, MC, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Van Zandt, MC1
Jones, ML1
Gunn, DE1
Geraci, LS1
Jones, JH1
Sawicki, DR1
Sredy, J1
Jacot, JL1
Dicioccio, AT1
Petrova, T1
Mitschler, A1
Podjarny, AD1

Other Studies

1 other study available for zopolrestat and Chronic Illness

ArticleYear
Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications.
    Journal of medicinal chemistry, 2005, May-05, Volume: 48, Issue:9

    Topics: Aldehyde Reductase; Animals; Cataract; Chronic Disease; Crystallography, X-Ray; Diabetes Complicatio

2005